HODGKIN DISEASE - MALIGNANCY, INFLAMMATION AND ABNORMAL IMMUNITY

被引：7

作者：

AGHAI, E

机构：

来源：

LEUKEMIA RESEARCH | 1986年 / 10卷 / 11期

关键词：

D O I：

10.1016/0145-2126(86)90332-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1267 / 1270

页数：4

共 58 条

[31]

KAPLAN HS, 1981, BLOOD, V57, P813

[32] EOSINOPHIL CHEMOTAXIS OF SUPERNATANTS FROM CULTURED HODGKINS LYMPH-NODE CELLS [J].

KAY, AB ;

MCVIE, JG ;

STUART, AE ;

KRAJEWSKI, A ;

TURNBULL, LW .

JOURNAL OF CLINICAL PATHOLOGY, 1975, 28 (06) :502-505

[33]

KNOWLES DM, 1984, CANCER, V54, P644, DOI 10.1002/1097-0142(1984)54:4<644::AID-CNCR2820540410>3.0.CO

[34]

2-A

[35] INTERLEUKIN-1-LIKE ACTIVITY CONSTITUTIVELY GENERATED BY HODGKIN DERIVED CELL-LINES .1. MEASUREMENT IN A HUMAN-LYMPHOCYTE COSTIMULATOR ASSAY [J].

KORTMANN, C ;

BURRICHTER, H ;

MONNER, D ;

JAHN, G ;

DIEHL, V ;

PETER, HH .

IMMUNOBIOLOGY, 1984, 166 (03) :318-333

[36] AMINO-ACID SEQUENCE OF A MAJOR NONIMMUNOGLOBULIN COMPONENT OF SOME AMYLOID FIBRILS [J].

LEVIN, M ;

PRAS, M ;

FRANGIONE, B ;

FRANKLIN, EC .

JOURNAL OF CLINICAL INVESTIGATION, 1972, 51 (10) :2773-+

[37]

MANY A, 1976, ACTA HAEMATOL-BASEL, V56, P1

[38]

MILLER TP, 1982, CANCER TREAT REP, V66, P645

[39]

NEWCOM SR, 1982, BLOOD, V60, P228

[40]

NEWCOM SR, 1985, J LAB CLIN MED, V105, P177

← 1 2 3 4 5 6 →